Optic atrophy following treatment with cobalt chloride in a patient with pancytopenia and hypercellular marrow.
D000328:Adult; D000741:Anemia, Aplastic / Q000188:drug therapy*; D001855:Bone Marrow Diseases / Q000150:complications*; D002712:Chlorides; D002829:Choroid / Q000098:blood supply; D003035:Cobalt / Q000008:administration & dosage / Q000009:adverse effects*; D005128:Eye Diseases / Q000139:chemically induced / Q000503:physiopathology; D005456:Fluorescent Dyes; D005654:Fundus Oculi; D006801:Humans; D008297:Male; D009896:Optic Atrophy / Q000139:chemically induced*; D010781:Photography; D012075:Remission, Spontaneous; D014786:Vision Disorders / Q000209:etiology; D014792:Visual Acuity
D002712:Chlorides; D005456:Fluorescent Dyes; D003035:Cobalt